Brokerage firm Barrington Research Downgrades its rating on U.S. Physical Therapy(USPH). The shares have been rated Market Perform. Previously, the analysts had a Outperform rating on the shares. The rating by the stock financial advisor at Barrington Research was issued on Mar 17, 2017 in a research report to their Investors and Clients.
U.S. Physical Therapy (USPH) shares turned negative on Wednesdays trading session with the shares closing down -0.6 points or -0.93% at a volume of 63,524. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $65. The peak price level was also seen at $65 while the days lowest was $63.7. Finally the shares closed at $64.15. The 52-week high of the shares is $78 while the 52-week low is $45.76. According to the latest information available, the market cap of the company is $803 M.
U.S. Physical Therapy(USPH) last announced its earnings results on Aug 4, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $90.43M. Analysts had an estimated revenue of $90.01M. Earnings per share were $0.57. Analysts had estimated an EPS of $0.55.
Several Insider Transactions has been reported to the SEC. On Dec 12, 2016, Edward L Kuntz (director) sold 2,500 shares at $68.40 per share price.Also, On Nov 22, 2016, Lawrance W Mcafee (Chief Financial Officer) sold 2,000 shares at $62.55 per share price.On Nov 16, 2016, Glenn Mcdowell (Chief Operating Officer) sold 4,047 shares at $61.15 per share price, according to the Form-4 filing with the securities and exchange commission.
U.S. Physical Therapy Inc. through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders sports-related injuries preventative care rehabilitation of injured workers and neurological-related injuries. The Company primarily operates through subsidiary clinic partnerships in which it owns a 1% general partnership interest and a 64% limited partnership interest and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company provides services at its clinics on an outpatient basis. Patients are treated for approximately one hour per day two to three times a week for two to six weeks. The Company operates approximately 489 clinics in 42 states of the United States.